Search Results

• • 11 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Viral and Host Biomarkers of HIV Remission Post Treatment Interruption.

  Authors:Leila B. Giron and Mohamed Abdel-MohsenFrom:Current HIV/AIDS Reports (Vol. 19, Issue 3)

  June 2022182 words Report, Brief articl...

   Abstract Only

• Evaluation of Sickle Cell Module for Quality of Life in Egyptian Children and Adolescents Patients: Impact of Psychiatric and Disease Specific Variables.

  Authors:Iman Ahmed Ragab, Mohamed Abdel-Mohsen Ellabody, Hisham Ahmed Ramy, Naglaa Fathy Mahmoud, and Safa Matbouly SayedFrom:Indian Journal of Hematology and Blood Transfusion (Vol. 37, Issue 4) Peer-Reviewed

  Oct. 2021247 words Report, Brief articl...

   Abstract Only

• Decreased HIV type 1 transcription in CCR5-?32 heterozygotes during suppressive antiretroviral therapy

  Authors:Charlene Wang, Mohamed Abdel-Mohsen, Matthew C. Strain, Steven M. Lada, Steven Yukl, Leslie R. Cockerham, et al.From:Journal of Infectious Diseases (Vol. 210, Issue 11) Peer-Reviewed

  Dec. 1, 2014 Report

   Citation Only

• HIV Antibody Level as a Marker of HIV Persistence and Low-Level Viral Replication

  Authors:Sheila M. Keating, Christopher D. Pilcher, Vivek Jain, Mila Lebedeva, Dylan Hampton, Mohamed Abdel-Mohsen, et al.From:Journal of Infectious Diseases (Vol. 216, Issue 1) Peer-Reviewed

  July 1, 2017 Article

   Citation Only

• HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial

  Authors:Robert M. Grant, Teri Liegler, Mohamed Abdel-Mohsen, L. Gordon Bentley, Robert Atchison, Timothy Schmidt, et al.From:Journal of Infectious Diseases (Vol. 210, Issue 8) Peer-Reviewed

  Oct. 15, 2014 Report

   Citation Only

• Role of MicroRNA Modulation in the Interferon-[alpha]/Ribavirin Suppression of HIV-1 In Vivo

  Authors:Mohamed Abdel-Mohsen, Xutao Deng, Ali Danesh, Teri Liegler, Evan S. Jacobs, Andri Rauch, et al.From:PLoS ONE (Vol. 9, Issue 10) Peer-Reviewed

  Oct. 2, 20147,081 words Article 1590LBackground Interferon-[alpha] (IFN-[alpha]) treatment suppresses HIV-1 viremia and reduces the size of the HIV-1 latent reservoir. Therefore, investigation of the molecular and immunologic effects of IFN-[alpha] may...

• Assessment of population-based HIV RNA levels in a rural East African setting using a fingerprick-based blood collection method

  Authors:Vivek Jain, Teri Liegler, Jane Kabami, Gabriel Chamie, Tamara D. Clark, Douglas Black, et al.From:Clinical Infectious Diseases (Vol. 56, Issue 4) Peer-Reviewed

  Feb. 15, 2013 Report

   Citation Only

• The Immunologic Effects of Mesalamine in Treated HIV-Infected Individuals with Incomplete CD4+ T Cell Recovery: A Randomized Crossover Trial

  Authors:Ma Somsouk, Richard M. Dunham, Michelle Cohen, Rebecca Albright, Mohamed Abdel-Mohsen, Teri Liegler, et al.From:PLoS ONE (Vol. 9, Issue 12) Peer-Reviewed

  Dec. 29, 20147,013 words Article 1780LThe anti-inflammatory agent, mesalamine (5-aminosalicylic acid) has been shown to decrease mucosal inflammation in ulcerative colitis. The effect of mesalamine in HIV-infected individuals, who exhibit abnormal mucosal...

• Role of retroviral restriction factors in the interferon-[alpha]-mediated suppression of HIV-1 in vivo

  Authors:Satish K. Pillai, Mohamed Abdel-Mohsen, John Guatelli, Mark Skasko, Alexander Monto, Katsuya Fujimoto, et al.From:Proceedings of the National Academy of Sciences of the United States (Vol. 109, Issue 8) Peer-Reviewed

  Feb. 21, 2012 Author abstract, Rep...

   Citation Only

• Recommendations for measuring HIV reservoir size in cure-directed clinical trials

  Authors:Mohamed Abdel-Mohsen, Douglas Richman, Robert F. Siliciano, Michel C. Nussenzweig, Bonnie J. Howell, Javier Martinez-Picado, et al.From:Nature Medicine (Vol. 26, Issue 9) Peer-Reviewed

  Sept. 202011,094 words Report 1650LTherapeutic strategies are being clinically tested either to eradicate latent HIV reservoirs or to achieve virologic control in the absence of antiretroviral therapy. Attaining this goal will require a consensus on how...

• Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis

  Authors:Florent Colomb, Leila B. Giron, Irena Trbojevic-Akmacic, Gordan Lauc, and Mohamed Abdel-MohsenFrom:Current HIV/AIDS Reports (Vol. 16, Issue 2)

  Apr. 2019318 words Report

   Abstract Only